₹ 0.6 Cr
Volume Transacted
(Jan 22, 2025)
6.5 K
Stocks Traded
(Jan 22, 2025)
Last Updated on: Jan 22, 2025
Zydus Lifesciences Ltd
NSE: ZYDUSLIFE
ISIN
INE010B01027
Last updated on: Jan 22, 2025
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Zydus Lifesciences Ltd
NSE: ZYDUSLIFE
Share Price
₹ 978.85
-6.90 (-0.70%)
Last updated on: Jan 22, 2025
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
21 Jan 2025 | 985.75 | 999.4 | 1006 | 983.75 |
20 Jan 2025 | 995.05 | 1013.35 | 1013.35 | 982 |
17 Jan 2025 | 994.15 | 989.7 | 1000.75 | 980.7 |
16 Jan 2025 | 988.8 | 990 | 994.45 | 979.7 |
15 Jan 2025 | 984.8 | 1007 | 1007 | 982 |
14 Jan 2025 | 1000.8 | 976.05 | 1003.2 | 976.05 |
13 Jan 2025 | 974.3 | 997.8 | 997.8 | 966.5 |
10 Jan 2025 | 1004.05 | 1010.15 | 1018.25 | 1001.25 |
09 Jan 2025 | 1009.4 | 1002.05 | 1027.35 | 997.95 |
08 Jan 2025 | 981.55 | 1010 | 1013 | 972.75 |
Date | Price (₹) |
---|---|
21 Jan 2025 | 985.75 |
20 Jan 2025 | 995.05 |
17 Jan 2025 | 994.15 |
16 Jan 2025 | 988.8 |
15 Jan 2025 | 984.8 |
14 Jan 2025 | 1000.8 |
13 Jan 2025 | 974.3 |
10 Jan 2025 | 1004.05 |
09 Jan 2025 | 1009.4 |
08 Jan 2025 | 981.55 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01031 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Last updated time: 22 Jan 15:30 PM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Zydus Lifesciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Zydus Lifesciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Zydus Life gains as Q1 PAT climbs 31% YoY to Rs 1,420 cr
Revenue from operations jumped 20.77% year on year (YoY) to Rs 6,207.5 crore in the quaret...
2024-08-09 00:00:00
Zydus Lifesciences consolidated net profit rises 30.64% in the June 2024 quarter
Net profit of Zydus Lifesciences rose 30.64% to Rs 1419.90 crore in the quarter ended June...
2024-08-09 00:00:00
Zydus receives USFDA approval for Valbenazine Capsules
Zydus Lifesciences has received final approval from the United States Food and Drug Admini...
2024-08-09 00:00:00
Zydus Lifesciences Ltd soars 1.83%, rises for third straight session
Zydus Lifesciences Ltd is up for a third straight session in a row. The stock is quoting a...
2024-08-08 00:00:00
Unlimited trading starting at just Rs. 249*